Medicine
Veltassa 1 g powder for oral suspension
Veltassa 1 g powder for oral suspension is a prescription medicine containing Patiromer for oral use, marketed by Vifor Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Veltassa should be stored in the refrigerator at 2°C to 8°C (36°F to 46°F). If…
Key facts
- Active ingredient (INN)
- Patiromer
- Brand
- Veltassa
- Strength
- 1 g
- Dosage form
- Powder for oral suspension
- Route
- Oral
- Packs
- 60 packets
- Marketing authorisation holder
- Vifor Pharma
- Manufacturer
- Vifor Pharma
- Origin register
- US FDA, United States
- Storage
- Veltassa should be stored in the refrigerator at 2°C to 8°C (36°F to 46°F). If stored at room temperature (25°C ± 2°C [77°F ± 4°F]), Veltassa must be used within 3 months of being taken out of the refrigerator. Avoid exposure to excessive heat above 40°C (104°F). For either storage condition, do not use Veltassa after the expiration date printed on the packet.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AE09 Patiromer
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 October 2024
- Identifiers
- RxCUI 1716209, 1716215, 1716217 +5DailyMed set ID bf002984-d6c9-46df-aecb-a07733f763c1NDC 53436-010Application NDA205739
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 packet in 1 carton / 1 powder, for suspension in 1 packet | 53436-010-60 | Vifor Pharma | 2 October 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Patiromer
Clinical summary
Patiromer is a potassium binder indicated for the treatment of hyperkalemia in adults and pediatric patients ages 12 years and older. It is available as powder for oral suspension. MedsAcross supplies Patiromer for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PatiromerFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VELTASSA prescribing information (Vifor Pharma) · U.S. National Library of Medicine, DailyMed
- Veltassa: European public assessment report (EPAR) · European Medicines Agency
Need Veltassa 1 g powder for oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.